| Document Date: 2011-06-26 22:21:38
Open Document File Size: 261,89 KBShare Result on Facebook
City Melbourne / / Company Eli Lilly and Co / Unilever / Page 2 STARPHARMA HOLDINGS LIMITED / DNT Inc / Australian Securities Exchange / Stiefel Laboratories / International plc / Qiagen / The Bank of New York Mellon / Market Starpharma Holdings Limited / Page 3 STARPHARMA HOLDINGS LIMITED / Dendritic Nanotechnologies Inc / Merck / Elanco / CVS / Starpharma Pty Ltd. / 2 Starpharma Holdings Limited / Acorn Capital / Siemens / Starpharma Holdings Limited / Report 3 Interim Financial Report 6 STARPHARMA HOLDINGS LTD / / Country United States / Australia / / Currency AUD / USD / / / Event Business Partnership / Earnings Announcement / FDA Phase / / Facility Baker Building / / / IndustryTerm pharmaceutical development product / dendrimer technology / dendrimer products / agricultural chemicals / electronics / life science applications / owned subsidiaries / finance costs / chemicals / depositary bank / / MedicalCondition HIV / genital herpes / HSV infection / bacterial vaginosis / Herpes / sexually transmitted infections / infection / / MedicalTreatment dendrimer / Dendrimers / / Organization Australia PO / US government / United States Government / / Person Dobinson J W Raff / Jenkins J K Fairley / Ellie Papathanasiou / Jackie Fairley Ben Rogers / / / Position Chief Executive Officer / epapathanasiou@bcg.com.au Chief Executive Officer / Company Secretary / Chairman / leader in the development / Deputy Chairman / / Product VivaGel / US / / ProvinceOrState Michigan / / Technology dendrimer technology / drug delivery / / URL www.starpharma.com / /
SocialTag |
Microsoft Word[removed]SPL App4D December 2009 ASX Final.doc